Bone Therapeutics SA Stock Euronext Bruxelles
Equities
BOTHE
BE0974280126
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.72M 2.91M 0 |
---|---|---|---|---|---|
Net income 2023 * | -5M -5.35M - | Net income 2024 * | -11M -11.77M - | EV / Sales 2023 * | - |
Net Debt 2023 * | 18.8M 20.12M 0 | Net Debt 2024 * | 29.3M 31.35M 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.3
x | P/E ratio 2024 * |
-0.16
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 73.22% |
Managers | Title | Age | Since |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-02 |
Nicco Carole
COO | Chief Operating Officer | - | 23-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+28.61% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.89% | 236B | |
+4.89% | 198B | |
-10.80% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- BIOS Stock
- BOTHE Stock